Circulating exosome-derived miR-122-5p is a novel biomarker for prediction of postoperative atrial fibrillation

J Cardiovasc Transl Res. 2022 Dec;15(6):1393-1405. doi: 10.1007/s12265-022-10267-4. Epub 2022 May 5.

Abstract

Postoperative atrial fibrillation (POAF) is a frequent complication associated with increased periprocedural mortality and morbidity after cardiac surgery. Our study aimed to identify the difference in exosomal miRNA and further explore its role in the diagnosis of POAF. First, the differentially expressed miRNAs (DEMs) were obtained by high-throughput RNA sequencing. Second, the DEMs target genes were put into gene ontology (GO) and KEGG pathway analysis. Third, real-time quantification PCR (RT-qPCR) was used to verify the DEMs. Finally, we revealed 23 DEMs in POAF patients. Furthermore, analysis of gene function revealed that DEMs may affect atrial structure through many signaling pathways. We also found that miR-122-5p was up-regulated in POAF patients, but there are no significant changes in miR-191-5p, miR-181a-5p, miR-155-5p and miR-151a-5p. Our study revealed that exosomal miRNAs exert enormous potential in evaluating the severity or prognostic of POAF.

Keywords: Exosomes; High-throughput RNA sequencing; Postoperative atrial fibrillation (POAF); microRNA (miRNA).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atrial Fibrillation* / etiology
  • Atrial Fibrillation* / genetics
  • Biomarkers
  • Exosomes* / genetics
  • Exosomes* / metabolism
  • Heart Atria / metabolism
  • Humans
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism

Substances

  • MicroRNAs
  • Biomarkers
  • MIRN122 microRNA, human